{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:33:41Z","timestamp":1783427621844,"version":"3.54.6"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMW","doi-asserted-by":"publisher","award":["10140022310037"],"award-info":[{"award-number":["10140022310037"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>The scarcity of robust long-term safety data has contributed to increasing restrictions on the use of gonadotropin-releasing hormone analog (GnRHa) treatment in transgender and gender diverse adolescents (TGDAs) in several countries. Methodological limitations of earlier studies have led to controversy and debate, underscoring the urgent need for high-quality evidence in this field<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To present a study design using target trial emulation (TTE) to evaluate long-term safety of GnRHa treatment in TGDAs using observational data from national healthcare registries, and highlight methodological challenges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We applied a stepwise TTE approach, to emulate a randomized trial using real-world data. The main methodological challenges were identified as the selection of the control group and the definition of time zero. To address these, we engaged independent experts in causal inference to review the concept design and provide feedback on potential solutions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results and Discussion<\/jats:title>\n                    <jats:p>Expert feedback was systematically summarized and discussed. The resulting study design will select late-presenting TGDA individuals as the control group and defines time zero as the initiation of GnRHa treatment for the intervention group, with the equivalent age assigned as time zero in controls. Sensitivity analyses using alternative control groups and time zero definitions will be included to assess robustness. This approach allows for adjustment of confounders and aims to emulate the conditions of a randomized trial as closely as possible within the constraints of observational data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This discussion paper serves as a methodological example of target trial emulation with observational data to study long-term safety of GnRHa in TGDA. By transparently addressing methodological challenges and incorporating expert input, this approach offers a feasible and ethically sound alternative to RCTs, and contributes to the evidence base needed for informed clinical and policy decisions in transgender healthcare.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ejendo\/lvag105","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:39:24Z","timestamp":1781613564000},"page":"848-856","source":"Crossref","is-referenced-by-count":1,"title":["From concept to protocol: iterative approach of a target trial emulation on GnRH analog safety in transgender and gender diverse youth"],"prefix":"10.1093","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4537-1761","authenticated-orcid":false,"given":"Gillian S","family":"Schuurman","sequence":"first","affiliation":[{"name":"Center of Expertise on Gender Dysphoria, Amsterdam University Medical Center , Amsterdam 1081 HV ,","place":["The Netherlands"]},{"name":"Department of Internal Medicine, Amsterdam University Medical Center , Amsterdam 1081 HV ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3620-5617","authenticated-orcid":false,"given":"Martin","family":"den Heijer","sequence":"additional","affiliation":[{"name":"Center of Expertise on Gender Dysphoria, Amsterdam University Medical Center , Amsterdam 1081 HV ,","place":["The Netherlands"]},{"name":"Department of Internal Medicine, Amsterdam University Medical Center , Amsterdam 1081 HV ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos W R","family":"Twisk","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Data Science, Amsterdam University Medical Center , Amsterdam-Zuidoost 1100 DD ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine E","family":"Hannema","sequence":"additional","affiliation":[{"name":"Center of Expertise on Gender Dysphoria, Amsterdam University Medical Center , Amsterdam 1081 HV ,","place":["The Netherlands"]},{"name":"Department of Internal Medicine, Amsterdam University Medical Center , Amsterdam 1081 HV ,","place":["The Netherlands"]},{"name":"Department of Pediatric Endocrinology, Amsterdam University Medical Center , Amsterdam 1105 AZ ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"11","key":"2026062513264310700_lvag105-B1","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"2026062513264310700_lvag105-B2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1159\/000542904","article-title":"Endocrine management of transgender and gender-diverse adolescents: expert opinion of the ESPE working group on gender incongruence and the endo-ERN main thematic group on sexual development and maturation","volume":"99","author":"Hannema","year":"2026","journal-title":"Horm Res Paediatr"},{"issue":"sup1","key":"2026062513264310700_lvag105-B3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgend Health"},{"issue":"7","key":"2026062513264310700_lvag105-B4","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.jsxm.2016.05.004","article-title":"Efficacy and safety of gonadotropin-releasing hormone agonist treatment to suppress puberty in gender dysphoric adolescents","volume":"13","author":"Schagen","year":"2016","journal-title":"J Sex Med"},{"issue":"11","key":"2026062513264310700_lvag105-B5","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1111\/apa.16791","article-title":"A systematic review of hormone treatment for children with gender dysphoria and recommendations for research","volume":"112","author":"Ludvigsson","year":"2023","journal-title":"Acta Paediatr"},{"issue":"12","key":"2026062513264310700_lvag105-B6","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S2352-4642(22)00254-1","article-title":"Continuation of gender-affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands","volume":"6","author":"van der Loos","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"3","key":"2026062513264310700_lvag105-B7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/jsxmed\/qdac029","article-title":"Children and adolescents in the Amsterdam cohort of gender dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch protocol","volume":"20","author":"van der Loos","year":"2023","journal-title":"J Sex Med"},{"issue":"3","key":"2026062513264310700_lvag105-B8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/ejendo\/lvad125","article-title":"Early puberty suppression and gender-affirming hormones do not alter final height in transgender adolescents","volume":"189","author":"Ciancia","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2026062513264310700_lvag105-B9","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/jamapediatrics.2023.4588","article-title":"Bone mineral density in transgender adolescents treated with puberty suppression and subsequent gender-affirming hormones","volume":"177","author":"van der Loos","year":"2023","journal-title":"JAMA Pediatr"},{"issue":"6","key":"2026062513264310700_lvag105-B10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/archdischild-2024-327909","article-title":"Puberty blockers for gender dysphoria in youth: a systematic review and meta-analysis","volume":"110","author":"Miroshnychenko","year":"2025","journal-title":"Arch Dis Child"},{"issue":"Suppl 2","key":"2026062513264310700_lvag105-B11","doi-asserted-by":"publisher","first-page":"s33","DOI":"10.1136\/archdischild-2023-326669","article-title":"Interventions to suppress puberty in adolescents experiencing gender dysphoria or incongruence: a systematic review","volume":"109","author":"Taylor","year":"2024","journal-title":"Arch Dis Child"},{"issue":"4","key":"2026062513264310700_lvag105-B12","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1089\/trgh.2020.0006","article-title":"Consensus parameter: research methodologies to evaluate neurodevelopmental effects of pubertal suppression in transgender youth","volume":"5","author":"Chen","year":"2020","journal-title":"Transgend Health"},{"issue":"3","key":"2026062513264310700_lvag105-B13","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1210\/jc.2018-01925","article-title":"Letter to the Editor: \u201cEndocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline\u201d","volume":"104","author":"Laidlaw","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"2026062513264310700_lvag105-B14","author":"Galvin"},{"key":"2026062513264310700_lvag105-B15"},{"issue":"11","key":"2026062513264310700_lvag105-B16","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1056\/NEJMp2416382","article-title":"Advancing transgender health amid rising policy threats","volume":"392","author":"Coelho","year":"2025","journal-title":"N Engl J Med"},{"issue":"4","key":"2026062513264310700_lvag105-B17","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1177\/13591045221091652","article-title":"Association between pre-treatment IQ and educational achievement after gender-affirming treatment including puberty suppression in transgender adolescents","volume":"27","author":"Arnoldussen","year":"2022","journal-title":"Clin Child Psychol Psychiatry"},{"issue":"8","key":"2026062513264310700_lvag105-B18","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1111\/j.1743-6109.2010.01943.x","article-title":"Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study","volume":"8","author":"de Vries","year":"2011","journal-title":"J Sex Med"},{"issue":"4","key":"2026062513264310700_lvag105-B19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/jsxmed\/qdae014","article-title":"A European network for the investigation of gender incongruence in adolescents","volume":"21","author":"Boogers","year":"2024","journal-title":"J Sex Med"},{"issue":"11","key":"2026062513264310700_lvag105-B20","doi-asserted-by":"publisher","first-page":"e032151","DOI":"10.1136\/bmjopen-2019-032151","article-title":"What are the health outcomes of trans and gender diverse young people in Australia? Study protocol for the Trans20 longitudinal cohort study","volume":"9","author":"Tollit","year":"2019","journal-title":"BMJ Open"},{"key":"2026062513264310700_lvag105-B21","author":"University of Colorado Denver"},{"issue":"3","key":"2026062513264310700_lvag105-B22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1056\/NEJMe2216191","article-title":"Growing evidence and remaining questions in adolescent transgender care","volume":"388","author":"de Vries","year":"2023","journal-title":"N Engl J Med"},{"key":"2026062513264310700_lvag105-B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17405629.2025.2485221","article-title":"How to improve research methodology in gender care: a non-binary choice","author":"Van Breukelen","journal-title":"Eur J Dev Psychol."},{"issue":"8","key":"2026062513264310700_lvag105-B24","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hernan","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"4","key":"2026062513264310700_lvag105-B25","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jsxm.2018.01.016","article-title":"The Amsterdam cohort of gender dysphoria study (1972-2015): trends in prevalence, treatment, and regrets","volume":"15","author":"Wiepjes","year":"2018","journal-title":"J Sex Med"},{"issue":"1","key":"2026062513264310700_lvag105-B26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/nrurol.2014.316","article-title":"Paediatrics: transgender medicine\u2013long-term outcomes from \u2018the Dutch model\u2019","volume":"12","author":"Shumer","year":"2015","journal-title":"Nat Rev Urol"},{"issue":"14","key":"2026062513264310700_lvag105-B27","doi-asserted-by":"publisher","first-page":"6367","DOI":"10.3390\/ijerph20146367","article-title":"Voices from a multidisciplinary healthcare center: understanding barriers in gender-affirming care-A qualitative exploration","volume":"20","author":"Ross","year":"2023","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"2026062513264310700_lvag105-B28","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1203\/00006450-200110000-00010","article-title":"Pubertal development in The Netherlands 1965-1997","volume":"50","author":"Mul","year":"2001","journal-title":"Pediatr Res"},{"issue":"7","key":"2026062513264310700_lvag105-B29","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/jech.2004.029496","article-title":"Estimating causal effects from epidemiological data","volume":"60","author":"Hernan","year":"2006","journal-title":"J Epidemiol Community Health"},{"issue":"3","key":"2026062513264310700_lvag105-B30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An Introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"10","key":"2026062513264310700_lvag105-B31","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/pds.4975","article-title":"Real-world evidence to support regulatory decision-making for medicines: considerations for external control arms","volume":"29","author":"Burcu","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3-4","key":"2026062513264310700_lvag105-B32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10742-014-0135-8","article-title":"A comparison of alternative strategies for choosing control populations in observational studies","volume":"15","author":"Steventon","year":"2015","journal-title":"Health Serv Outcomes Res Methodol"},{"issue":"12","key":"2026062513264310700_lvag105-B33","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.2337\/dc12-0788","article-title":"Metformin and the risk of cancer: time-related biases in observational studies","volume":"35","author":"Suissa","year":"2012","journal-title":"Diabetes Care"},{"key":"2026062513264310700_lvag105-B34","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.2147\/CLEP.S328342","article-title":"Avoiding time-related biases: a feasibility study on antidiabetic drugs and pancreatic cancer applying the parametric g-formula to a large German healthcare database","volume":"13","author":"Bornhorst","year":"2021","journal-title":"Clin Epidemiol"},{"key":"2026062513264310700_lvag105-B35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jclinepi.2016.04.014","article-title":"Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses","volume":"79","author":"Hernan","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"2026062513264310700_lvag105-B36","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41366-023-01334-0","article-title":"Filling a gap in care: addressing obesity in transgender and gender diverse patients","volume":"47","author":"Taormina","year":"2023","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"2026062513264310700_lvag105-B37","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.jadohealth.2020.07.033","article-title":"Psychosocial characteristics of transgender youth seeking gender-affirming medical treatment: baseline findings from the trans youth care study","volume":"68","author":"Chen","year":"2021","journal-title":"J Adolesc Health"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvag105\/68542865\/lvag105.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/6\/848\/68542865\/lvag105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/194\/6\/848\/68542865\/lvag105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:26:49Z","timestamp":1782408409000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/194\/6\/848\/8709984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvag105","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,6,1]]}}}